ATE224912T1 - Verfahren zur herstellung von peptiden - Google Patents

Verfahren zur herstellung von peptiden

Info

Publication number
ATE224912T1
ATE224912T1 AT97927386T AT97927386T ATE224912T1 AT E224912 T1 ATE224912 T1 AT E224912T1 AT 97927386 T AT97927386 T AT 97927386T AT 97927386 T AT97927386 T AT 97927386T AT E224912 T1 ATE224912 T1 AT E224912T1
Authority
AT
Austria
Prior art keywords
peptide
formula
defined above
optionally
substituted
Prior art date
Application number
AT97927386T
Other languages
English (en)
Inventor
Chitoshi Hatanaka
Yasuaki Abe
Mitsuhisa Yamano
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE224912T1 publication Critical patent/ATE224912T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
AT97927386T 1996-06-21 1997-06-19 Verfahren zur herstellung von peptiden ATE224912T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16179196 1996-06-21
PCT/JP1997/002097 WO1997048726A1 (en) 1996-06-21 1997-06-19 Method for producing peptides

Publications (1)

Publication Number Publication Date
ATE224912T1 true ATE224912T1 (de) 2002-10-15

Family

ID=15741986

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97927386T ATE224912T1 (de) 1996-06-21 1997-06-19 Verfahren zur herstellung von peptiden

Country Status (13)

Country Link
US (1) US6211333B1 (de)
EP (1) EP0910575B1 (de)
KR (1) KR100459978B1 (de)
CN (1) CN1129607C (de)
AT (1) ATE224912T1 (de)
AU (1) AU3189997A (de)
CA (1) CA2257381C (de)
DE (1) DE69715860T2 (de)
DK (1) DK0910575T3 (de)
ES (1) ES2184096T3 (de)
IL (3) IL127312A0 (de)
PT (1) PT910575E (de)
WO (1) WO1997048726A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6559127B1 (en) 1997-07-31 2003-05-06 Athena Neurosciences, Inc. Compounds which inhibit leukocyte adhesion mediated by VLA-4
US6939855B2 (en) 1997-07-31 2005-09-06 Elan Pharmaceuticals, Inc. Anti-inflammatory compositions and method
ATE455106T1 (de) 1999-01-22 2010-01-15 Elan Pharm Inc Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen
US6407066B1 (en) 1999-01-26 2002-06-18 Elan Pharmaceuticals, Inc. Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4
EP1144435B1 (de) * 1999-01-26 2006-04-12 Elan Pharmaceuticals, Inc. Pyroglutaminsäurederivate und damit verwandte verbindungen, die die durch vla-4 vermittelte leukozytenadhäsion verringern
WO2001002428A1 (en) * 1999-06-30 2001-01-11 Takeda Chemical Industries, Ltd. Process for the preparation of lh-rh derivatives
TW200307671A (en) 2002-05-24 2003-12-16 Elan Pharm Inc Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
TWI281470B (en) 2002-05-24 2007-05-21 Elan Pharm Inc Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
ES2444215T3 (es) * 2002-07-29 2014-02-24 Zymtech Production As Método para la producción de péptidos y aminoácidos a partir de material de origen animal que comprende proteínas
ES2336826T3 (es) * 2005-05-03 2010-04-16 Novetide, Ltd. Procedimientos para la produccion de un peptido que presenta una amida c-terminal.
BRPI0616687A2 (pt) 2005-09-29 2011-06-28 Elan Pharm Inc compostos de pirimidinil amida que inibem a adesão leucocitária mediada por vla-4
CA2624524C (en) 2005-09-29 2014-07-08 Elan Pharmaceuticals, Inc. Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
CA2643838A1 (en) 2006-02-27 2007-09-07 Elan Pharmaceuticals, Inc. Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4
WO2010126914A1 (en) 2009-04-27 2010-11-04 Elan Pharmaceuticals, Inc. Pyridinone antagonists of alpha-4 integrins
JP6564539B1 (ja) * 2018-09-14 2019-08-21 長瀬産業株式会社 スルホン酸化合物によるペプチド精製方法
CN113527438A (zh) * 2021-08-30 2021-10-22 湖南三太药业有限公司 一种全液相合成丙氨瑞林的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947569A (en) * 1972-04-12 1976-03-30 American Home Products Corporation Process for preparing the releasing hormone of luteinizing hormone (LH) and of follicle stimulating hormone (FSH), salts and compositions thereof, and intermediates therefor
US3855198A (en) 1972-09-29 1974-12-17 American Home Prod Novel intermediates for synthesis of l-(5-oxoprolyl)-l-histidy-l-tryptophyl-l-seryl-l-tyrosyl-l-glycyl-l-leucyl-l-arginyl-l-prolyl-glycine amide
JPS49100081A (de) 1973-01-30 1974-09-20
CA1023350A (en) 1974-01-21 1977-12-27 Manfred K. Gotz Derivatives of the lh- and fsh-releasing hormone
CH611878A5 (de) 1974-07-04 1979-06-29 Takeda Chemical Industries Ltd
DE3163800D1 (en) 1980-02-12 1984-07-05 Takeda Chemical Industries Ltd Method for protecting guanidino group and restoring the same
IT1178775B (it) * 1983-12-23 1987-09-16 Konzponti Valto Es Hitelbank R Derivati della gonadoliberina e procedimento per la loro preparazione
DE68928278T2 (de) 1988-02-10 1998-03-12 Tap Pharmaceuticals Inc Lhrh-analog

Also Published As

Publication number Publication date
CA2257381C (en) 2007-08-21
US6211333B1 (en) 2001-04-03
PT910575E (pt) 2003-02-28
KR20000016798A (ko) 2000-03-25
IL163521A (en) 2007-07-04
KR100459978B1 (ko) 2005-01-15
ES2184096T3 (es) 2003-04-01
CN1129607C (zh) 2003-12-03
AU3189997A (en) 1998-01-07
EP0910575B1 (de) 2002-09-25
DE69715860T2 (de) 2003-08-07
CN1222916A (zh) 1999-07-14
WO1997048726A1 (en) 1997-12-24
CA2257381A1 (en) 1997-12-24
IL127312A0 (en) 1999-09-22
DE69715860D1 (de) 2002-10-31
IL163521A0 (en) 2005-12-18
DK0910575T3 (da) 2003-02-03
EP0910575A1 (de) 1999-04-28

Similar Documents

Publication Publication Date Title
DE69715860D1 (de) Verfahren zur herstellung von peptiden
SE8403931L (sv) Treo-3-amino-2-hydroxi-4-oxosmorsyraderivat
KR870002161A (ko) 옥사-및 아자 호모사이클로 스타틴 폴리펩티드의 제조방법
DE69636987D1 (de) Mittel zur förderung von knochenbildung
DE69408599D1 (de) Verfahren zur Herstellung von Taurocholansäure
KR900009692A (ko) 레트로바이러스 프로테아제 억제제
ES461987A3 (es) Procedimiento para la fabricacion de nuevos gona-4,9 (10) dienos.
HU896606D0 (en) Process for the preparation of aminoacid derivatives inhibiting enzymes and pharmaceutical compositions thereof
KR840007571A (ko) 락탐 펩티드의 제조방법
GB1510477A (en) Peptides and to amino acid intermediates thereof
US3757003A (en) Process for preparing l pyroglutamyl l histidyl l prolinamide
EP0297456A3 (de) Immunsuppressive Peptide
ES453304A1 (es) Un procedimiento para la preparacion de nuevos derivados de aminoacidos.
ATE119202T1 (de) Verfahren zur herstellung von l-aminosäuren und aminosäure-amiden.
ZA877862B (en) The synthesis of peptide aminoalkylamides and peptide hydrazides by the solid-phase method
ATE13527T1 (de) Verfahren zur herstellung von beta-hydroxy-alpha- aminocarbonsaeuren.
DE69525169D1 (de) Verfahren zur herstellung von n-carboxyanhydridaminosäuren aus n-(n'-nitrosocarbamoyl)-aminosäuren
ATE206134T1 (de) Verfahren zur herstellung von alpha- aminosäureamiden zur verwendung in der peptidsynthese
PT79195A (de) Verfahren zur herstellung von carbonsaeureamidgruppen enthaltenden verbindungen insbesondere von peptiden
ATE18206T1 (de) Verfahren zur herstellung eines laktams.
DE59602077D1 (de) Verfahren zur Herstellung von (4,5)-trans-Oxazolidin-derivaten
JPS55127353A (en) Gamma-rearrangement of alpha-glutamylpeptide
JPS5772950A (en) Tetrapeptide derivative, its preparation and analgesic agent
ES482419A1 (es) Un procedimiento para la preparacion de eteres del acido - clavulanico.
MX9707319A (es) Acido alfa, gamma-diaminobutirico (dab) que contiene derivados oligopeptidicos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0910575

Country of ref document: EP